Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria

Journal of Korean Medical Science

Volumn 24, Issue 4, 2009, Pages 621-626

  Hwang, Yong Il ^a   Kim, Chang Hwan ^a   Kang, Hye Ryun ^a   Shin, Taerim ^a   Park, Sang Myeon ^a   Jang, Seung Hun ^a   Park, Yong Bum ^a   Kim, Cheol Hong ^a   Kim, Dong Gyu ^a   Lee, Myung Goo ^a   Hyun, In Gyu ^a   Jung, K S ^a  

^a Hallym University   (South Korea)

Author keywords

Chronic obstructive; Lower limit of normal; National prevalence; Pulmonary disease; Spirometry

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PREVALENCE; RISK; SPIROMETRY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; SPIROMETRY;

EID: 70350705991     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.4.621     Document Type: Article

References (27)

1. National Heart, Lung, and Blood Institute and World Health Organization. Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA [revised 2006; cited 25 January 2007]. Available from: URL: http://www.goldcopd.com
2. Murray CJ, Lopez AD. Evidence-based health policy-Lessons from the global burden of disease study. Science 1996; 274: 740-3.
3. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease. Lancet 1997; 349: 1436-42.
4. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-504.
5. Hurd SS. International efforts directed at attacking the problem of COPD. Chest 2000; 117: S336-8.
6. Snider GL. Nosology for our day-Its application to chronic obstructive pulmonary pisease. Am J Respir Crit Care Med 2003; 167: 678-83.
7. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, Rees J. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-420.
8. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77-121.
9. British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52: S1-28.
10. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of ATS/ERS position paper. Eur Respir J 2004; 23: 932-46.
11. Kim DS, Kim YS, Jung K, Chang JH, Lim C, Lee JH, Uh S, Shim JJ Lew WJ. Prevalence of chronic obstructive pulmonary disease in Korea. Am J Respir Crit Care Med 2005; 172: 842-47.
12. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly neversmoker. Eur Respir J 2002; 20: 1117-22.
13. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coated A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. "ATS/ERS task force: standardisation of lung function testing" Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-68.
14. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry for Korean population. Tuberc Respir Dis (Korean) 2005; 58: 230-42.
15. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R,k Enright P, vsn der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. "ATS/ERS task force: standardisation of lung function testing". Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
16. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-18.
17. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22: 268-73.
18. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659-64.
19. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-34.
20. Enright PL, Kronmal RA, Higgins M, Schenker M, Haponik EF. Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular Health Study. Am Rev Respir Dis 1993; 147: 125-33.
21. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Forced spirometry reference values for Norwegian adults: the Bronchial obstruction in Nord-Trondelag study. Eur Respir J 2001; 18: 770-9.
22. Korean National Statistical Office. Estimated Korean population based on Bureau of the Census 2001 data. Available from: http://www.nso.go.kr [accessed January 2007].
23. Iqbal A, Schloss S, George D, Isonaka. Worldwide guidelines for chronic obstructive pulmonary disease: a comparison of diagnosis and treatment recommendations. Respirology 2002; 7: 233-9.
24. Viegi G, Pedreschi M, Pistelli F, Pede FD, Baldacci S, Carrozzi L, Giuntini C. Prevalence of airways obstruction in a general population. European respiratory society vs American thoracic society definition. Chest 2000; 117: S339-45.
25. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction. Chest 2007; 131: 349-55.
26. Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Post-bronchodilator spirometry reference values in adults and implication for disease management. Am J Respir Crit Care Med 2006; 173: 1316-25.
27. Brusasco V, Pellegrino R, Rodarte JR. Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories. Eur Respir J 1997; 10: 1316-20.